Livingston B - Search Results

1

Epitope identification and vaccine design for cancer immunotherapy.

Sette A, Keogh E, Ishioka G, Sidney J, Tangri S, Livingston B, McKinney D, Newman M, Chesnut R, Fikes J. Sette A, et al. Among authors: livingston b. Curr Opin Investig Drugs. 2002 Jan;3(1):132-9. Curr Opin Investig Drugs. 2002. PMID: 12054064 Review.

2

T-lymphocyte epitope identification and their use in vaccine development for HIV-1.

Newman MJ, Livingston B, McKinney DM, Chesnut RW, Sette A. Newman MJ, et al. Among authors: livingston b. Front Biosci. 2002 Jun 1;7:d1503-15. doi: 10.2741/A730. Front Biosci. 2002. PMID: 12048179 Review.

3

The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation.

Sette A, Livingston B, McKinney D, Appella E, Fikes J, Sidney J, Newman M, Chesnut R. Sette A, et al. Among authors: livingston b. Biologicals. 2001 Sep-Dec;29(3-4):271-6. doi: 10.1006/biol.2001.0297. Biologicals. 2001. PMID: 11851327

4

Optimizing vaccine design for cellular processing, MHC binding and TCR recognition.

Sette A, Newman M, Livingston B, McKinney D, Sidney J, Ishioka G, Tangri S, Alexander J, Fikes J, Chesnut R. Sette A, et al. Among authors: livingston b. Tissue Antigens. 2002 Jun;59(6):443-51. doi: 10.1034/j.1399-0039.2002.590601.x. Tissue Antigens. 2002. PMID: 12445314 Review.

5

Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL.

McKinney DM, Skvoretz R, Livingston BD, Wilson CC, Anders M, Chesnut RW, Sette A, Essex M, Novitsky V, Newman MJ. McKinney DM, et al. J Immunol. 2004 Aug 1;173(3):1941-50. doi: 10.4049/jimmunol.173.3.1941. J Immunol. 2004. PMID: 15265928

6

A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes.

Livingston B, Crimi C, Newman M, Higashimoto Y, Appella E, Sidney J, Sette A. Livingston B, et al. J Immunol. 2002 Jun 1;168(11):5499-506. doi: 10.4049/jimmunol.168.11.5499. J Immunol. 2002. PMID: 12023344

7

Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules.

Livingston BD, Crimi C, Fikes J, Chesnut RW, Sidney J, Sette A. Livingston BD, et al. Hum Immunol. 1999 Nov;60(11):1013-7. doi: 10.1016/s0198-8859(99)00103-2. Hum Immunol. 1999. PMID: 10599997

8

Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines.

Livingston BD, Newman M, Crimi C, McKinney D, Chesnut R, Sette A. Livingston BD, et al. Vaccine. 2001 Sep 14;19(32):4652-60. doi: 10.1016/s0264-410x(01)00233-x. Vaccine. 2001. PMID: 11535313

9

Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome.

Wentworth PA, Sette A, Celis E, Sidney J, Southwood S, Crimi C, Stitely S, Keogh E, Wong NC, Livingston B, Alazard D, Vitiello A, Grey HM, Chisari FV, Chesnut RW, Fikes J. Wentworth PA, et al. Among authors: livingston b. Int Immunol. 1996 May;8(5):651-9. doi: 10.1093/intimm/8.5.651. Int Immunol. 1996. PMID: 8671652

10

The optimization of helper T lymphocyte (HTL) function in vaccine development.

Alexander J, Fikes J, Hoffman S, Franke E, Sacci J, Appella E, Chisari FV, Guidotti LG, Chesnut RW, Livingston B, Sette A. Alexander J, et al. Among authors: livingston b. Immunol Res. 1998;18(2):79-92. doi: 10.1007/BF02788751. Immunol Res. 1998. PMID: 9844827 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters